EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters

Gerard Agbayani, Bassel Akache, Tyler M Renner, Anh Tran, Matthew Stuible, Renu Dudani, Blair A Harrison iD, Diana Duque, Jegarubee Bavananthasivam, Lise Deschatelets, Usha D Hemraz, Sophie Régnier und 2 weitere

European Journal of Immunology · 2024

DOI: 10.1002/eji.202350620 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2024. Verfasst von Gerard Agbayani und 13 weiteren Autor:innen. Beteiligte Einrichtung: Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Administration, Intranasal, Spike Glycoprotein, Coronavirus, SARS-CoV-2, COVID-19 Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Council Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With the continued transmission of SARS‐CoV‐2 across widely vaccinated populations, it remains important to develop new vaccines and vaccination strategies capable of providing protective immunity and limiting the spread of disease. Heterologous prime‐boost vaccination based on the selection of different vaccine formulations and administration routes for priming and booster doses presents a promising strategy for inducing broader immune responses in key systemic and respiratory mucosal compartments. Intranasal vaccination can induce mucosal immune responses at the site of SARS‐CoV‐2 infection; however, the lack of clinically approved mucosal adjuvants makes it difficult to induce robust immune responses with protein subunit vaccines. Herein, we evaluated the immunogenicity of heterologous prime‐boost regimens in mice and hamsters based on a parenteral vaccination of the antigen in combination with sulfated lactosylarchaeol (SLA) archaeosomes, a liposome adjuvant comprised of a single semisynthetic archaeal lipid, followed by an intranasally administered unadjuvanted SARS‐CoV‐2 spike antigen. Intranasal administration of unadjuvanted spike to mice and hamsters increased serum spike‐specific IgG titers and spike‐neutralizing activity compared with nonboosted animals. Spike‐specific IgA responses were also detected in the bronchoalveolar lavage fluid in the lungs of mice that received an intranasal boost. In hamsters, the intranasal boost showed high efficacy against SARS‐CoV‐2 infection by protecting from body weight loss and reducing viral titers in the lungs and nasal turbinate. Overall, our heterologous intramuscular prime‐intranasal boost with SLA‐adjuvanted and unadjuvanted spike, respectively, demonstrated the potential of protein subunit formulations to promote antigen‐specific systemic and mucosal immune responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, IntranasalSpike Glycoprotein, CoronavirusSARS-CoV-2COVID-19 VaccinesVaccines, SubunitCOVID-19Antibodies, ViralAnimalsMiceCricetinaeFemaleAntibodies, NeutralizingImmunization, SecondaryAdjuvants, ImmunologicMice, Inbred BALB CImmunity, MucosalHumansVaccination

Stichwörter der Autor:innen

ArchaeosomesInfectious diseasesIntranasal vaccinesMucosal immunityProtein subunit vaccines

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 VaccinesVaccines, SubunitAntibodies, ViralAntibodies, NeutralizingAdjuvants, Immunologic

Autor:innen und Institutionen

  • Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, Ontario, Canada.
  • Human Health Therapeutics Research Centre, National Research Council Canada, Montreal, Quebec, Canada.
  • Aquatic and Crop Resource Development Research Centre, National Research Council Canada, Montreal, Quebec, Canada.

ORCID-Profile: Blair A Harrison

Förderung

  • National Research Council Canada

Zitieren

APA

Agbayani, G., Akache, B., Renner, T. M., Tran, A., Stuible, M., Dudani, R., Harrison, B. A., Duque, D., Bavananthasivam, J., Deschatelets, L., Hemraz, U. D., Régnier, S., Durocher, Y., & McCluskie, M. J. (2024). Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters. European Journal of Immunology. https://doi.org/10.1002/eji.202350620

Vancouver

Agbayani G, Akache B, Renner TM, Tran A, Stuible M, Dudani R, et al. Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters. European Journal of Immunology. 2024. doi:10.1002/eji.202350620

BibTeX
@article{Agbayani2024,
  author = {Agbayani, Gerard and Akache, Bassel and Renner, Tyler M and Tran, Anh and Stuible, Matthew and Dudani, Renu and Harrison, Blair A and Duque, Diana and Bavananthasivam, Jegarubee and Deschatelets, Lise and Hemraz, Usha D and Régnier, Sophie and Durocher, Yves and McCluskie, Michael J},
  title = {Intranasal administration of unadjuvanted SARS‐CoV‐2 spike antigen boosts antigen‐specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters},
  journal = {European Journal of Immunology},
  year = {2024},
  doi = {10.1002/eji.202350620}
}
Kostenlos starten →